Merus Dirección
Dirección controles de criterios 4/4
El CEO de Merus' es Bill Lundberg , nombrado en Dec 2019, tiene una permanencia de 4.33 años. compensación anual total es $4.67M, compuesta por 13.9% salario y 86.1% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.26% de las acciones de la empresa, por valor de $6.21M. La antigüedad media del equipo directivo y de la junta directiva es de 4 años y 5.7 años, respectivamente.
Información clave
Bill Lundberg
Chief Executive Officer (CEO)
US$4.7m
Compensación total
| Porcentaje del salario del CEO | 13.9% |
| Permanencia del CEO | 4.4yrs |
| Participación del CEO | 0.3% |
| Permanencia media de la dirección | 4.1yrs |
| Promedio de permanencia en la Junta Directiva | 5.8yrs |
Actualizaciones recientes de la dirección
Recent updates
Merus: Positive Zenocutuzumab Data In 2024 Could Provide BLA Advancement
Mar 01Merus N.V.'s (NASDAQ:MRUS) Shares Climb 30% But Its Business Is Yet to Catch Up
Feb 01
Merus Stock: Rally Seems Overdone
Jan 23Are Investors Undervaluing Merus N.V. (NASDAQ:MRUS) By 45%?
Jan 14Risks To Shareholder Returns Are Elevated At These Prices For Merus N.V. (NASDAQ:MRUS)
Dec 18We Think Merus (NASDAQ:MRUS) Needs To Drive Business Growth Carefully
Sep 19Merus N.V.'s (NASDAQ:MRUS) Business Is Yet to Catch Up With Its Share Price
Jun 20Is Merus (NASDAQ:MRUS) In A Good Position To Invest In Growth?
May 24Merus N.V. (NASDAQ:MRUS) Shares Could Be 26% Below Their Intrinsic Value Estimate
Feb 08Merus GAAP EPS of -$0.13 beats by $0.49, revenue of $12.68M beats by $2.23M
Aug 08Merus N.V. initiated with Buy at Stifel based on three bispecific antibodies
Aug 02Merus: Precision Oncology Pioneer Continues To Execute In The Clinic
Jun 30Need To Know: Analysts Are Much More Bullish On Merus N.V. (NASDAQ:MRUS)
May 14Merus (NASDAQ:MRUS) Is In A Strong Position To Grow Its Business
Apr 25New Forecasts: Here's What Analysts Think The Future Holds For Merus N.V. (NASDAQ:MRUS)
Mar 03We're Not Worried About Merus' (NASDAQ:MRUS) Cash Burn
Nov 25News Flash: Analysts Just Made A Sizeable Upgrade To Their Merus N.V. (NASDAQ:MRUS) Forecasts
Aug 08Calculating The Intrinsic Value Of Merus N.V. (NASDAQ:MRUS)
Jul 28We're Not Very Worried About Merus' (NASDAQ:MRUS) Cash Burn Rate
Jul 02Merus posts positive efficacy data from early-stage zenocutuzumab cancer study
Jun 04Merus EPS misses by $0.10, misses on revenue
May 06Is Merus N.V. (NASDAQ:MRUS) Popular Amongst Institutions?
Mar 08Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | US$5m | US$650k | -US$155m |
| Sep 30 2023 | n/a | n/a | -US$177m |
| Jun 30 2023 | n/a | n/a | -US$178m |
| Mar 31 2023 | n/a | n/a | -US$152m |
| Dec 31 2022 | US$6m | US$599k | -US$131m |
| Sep 30 2022 | n/a | n/a | -US$64m |
| Jun 30 2022 | n/a | n/a | -US$54m |
| Mar 31 2022 | n/a | n/a | -US$76m |
| Dec 31 2021 | US$8m | US$582k | -US$67m |
| Sep 30 2021 | n/a | n/a | -US$80m |
| Jun 30 2021 | n/a | n/a | -US$89m |
| Mar 31 2021 | n/a | n/a | -US$79m |
| Dec 31 2020 | US$5m | US$565k | -US$86m |
| Sep 30 2020 | n/a | n/a | -US$83m |
| Jun 30 2020 | n/a | n/a | -US$69m |
| Mar 31 2020 | n/a | n/a | -US$65m |
| Dec 31 2019 | US$162k | n/a | -US$55m |
Compensación vs. Mercado: La compensación total ($USD4.67M) de Bill está en línea con el promedio de empresas de tamaño similar en el mercado US ($USD5.55M).
Compensación vs. Ingresos: La compensación de Bill ha sido consistente con los resultados de la empresa en el último año.
CEO
Bill Lundberg (60 yo)
4.4yrs
Permanencia
US$4,671,327
Compensación
Dr. Sven Ante Lundberg, also known as Bill, M.D. is Venture Advisor of Forge Life Science Partners. He serves as Chief Executive Officer, President and Executive Director of Merus N.V. since December 31, 2...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO, President & Executive Director | 4.4yrs | US$4.67m | 0.26% $ 6.8m | |
| Chief Financial Officer | less than a year | US$6.21m | 0% $ 0 | |
| EVP, Company Secretary | 6.3yrs | US$1.95m | 0% $ 0 | |
| Chief Business Officer | 8.4yrs | US$1.69m | 0.27% $ 7.0m | |
| Chief Medical Officer & Senior VP | 3.8yrs | US$1.66m | 0% $ 0 | |
| Co-Founder and Scientific Advisor | no data | sin datos | sin datos | |
| Chief Accounting Officer | no data | sin datos | 0.012% $ 314.4k | |
| CTO & Executive VP | 11.3yrs | US$609.22k | sin datos | |
| Chief Scientific Officer & Senior VP | 3yrs | sin datos | sin datos | |
| IR & Corporate Communications Officer | no data | sin datos | sin datos | |
| Executive VP | no data | US$647.63k | sin datos | |
| Executive VP & Chief Commercial Officer | 2.3yrs | sin datos | sin datos |
4.1yrs
Permanencia media
57yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de MRUS se considera experimentado (4 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO, President & Executive Director | 4.9yrs | US$4.67m | 0.26% $ 6.8m | |
| Board Observer | 14.3yrs | sin datos | sin datos | |
| Independent Non-Executive Director | 3yrs | US$305.06k | 0% $ 0 | |
| Independent Chairman | 8.8yrs | US$417.56k | 0% $ 0 | |
| Independent Non-Executive Director | 3.9yrs | US$309.56k | 0% $ 0 | |
| Independent Non Executive Director | 8.9yrs | US$311.06k | 0.13% $ 3.3m | |
| Member of Scientific Advisory Board | 5.8yrs | sin datos | sin datos | |
| Independent Non-Executive Director | 4.9yrs | US$292.48k | 0% $ 0 | |
| Member of Scientific Advisory Board | 5.8yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 5.8yrs | sin datos | sin datos | |
| Independent Non-Executive Director | 5.8yrs | US$303.56k | 0% $ 0 |
5.8yrs
Permanencia media
60yo
Promedio de edad
Junta con experiencia: La junta directiva de MRUS se considera experimentada (5.7 años de antigüedad promedio).